Stem Cell Therapies: To the Clinic Through the Clinic

Posted by

SELECTBIO

Michael Whitaker, Dean of Research & Innovation, Newcastle University

Abstract
Stem cell-based regenerative medicine shows much promise. The challenge is to develop safe and cost-effective therapies. Existing biotech business models are sorely stretched when applied to cellular therapies. Market models based on close clinician-company partnerships are likely to bring the earliest successes.